Microbiome Analysis of Bile Samples in Patients with Choledocholithiasis and Hepatobiliary Disorders
Abstract
Introduction
Methods
Patients and sample collection
Culture and characterization of the bacterial isolates
DNA extraction from bile samples
16S rDNA sequencing, OTU analysis, alignment, and classification
Results
Patients and infection
16S rDNA sequencing
Effects on richness and diversity
Discussion
Conclusions
Supplementary Materials




Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bansal, A.; Akhtar, M.; Bansal, A.K. A clinical study: prevalence and management of cholelithiasis. Int Surg J 2014, 1, 134–139. [Google Scholar] [CrossRef]
- Stinton, L.M.; Shaffer, E.A. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012, 6, 172–187. [Google Scholar] [CrossRef]
- Wang, D.Q.; Cohen, D.E.; Carey, M.C. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009, 50 (Suppl), S406–S411. [Google Scholar] [CrossRef] [PubMed]
- Vítek, L.; Carey, M.C. New pathophysiological concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol 2012, 36, 122–129. [Google Scholar] [CrossRef] [PubMed]
- Reshetnyak, V.I. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol 2012, 4, 18–34. [Google Scholar] [CrossRef]
- Wang, H.H.; Portincasa, P.; Liu, M.; Tso, P.; Wang, D.Q. Similarities and differences between biliary sludge and microlithiasis: their clinical and pathophysiological significances. Liver Res 2018, 2, 186–199. [Google Scholar] [CrossRef] [PubMed]
- Petrov, V.A.; Fernández-Peralbo, M.A.; Derks, R.; et al. Biliary microbiota and bile acids composition in cholelithiasis. Biomed Res Int 2020, 1242364. [Google Scholar] [CrossRef]
- Schneider, J.; De Waha, P.; Hapfelmeier, A.; et al. Risk factors for increased antimicrobial resistance: a retrospective analysis of 309 acute cholangitis episodes. J Antimicrob Chemother 2014, 69, 519–525. [Google Scholar] [CrossRef]
- Swidsinski, A.; Khilkin, M.; Pahlig, H.; Swidsinski, S.; Priem, F. Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology 1998, 27, 662–665. [Google Scholar] [CrossRef]
- Cavaletti, L.; Monciardini, P.; Bamonte, R.; et al. New lineage of filamentous, spore-forming, gram-positive bacteria from soil. Appl Environ Microbiol 2006, 72, 4360–4369. [Google Scholar] [CrossRef]
- Salipante, S.J.; Sengupta, D.J.; Rosenthal, C.; et al. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 2013, 8, e65226. [Google Scholar] [CrossRef]
- Holt, J.G.; Williams, S.T.; Holt. Bergey’s manual of systematic bacteriology, Vol. 4; Lippincott Williams & Wilkins: Baltimore, 1989. [Google Scholar]
- Sambrook, J.; Russell, D.W. Purification of nucleic acids by extraction with phenol: chloroform. CSH Protoc 2006, pdb.prot4455. [Google Scholar] [CrossRef]
- Walker, A.W.; Martin, J.C.; Scott, P.; Parkhill, J.; Flint, H.J.; Scott, K.P. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome 2015, 3, 26. [Google Scholar] [CrossRef]
- Ye, F.; Shen, H.; Li, Z.; et al. Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS One 2016, 11, e0150519. [Google Scholar] [CrossRef] [PubMed]
- Wu, T.; Zhang, Z.; Liu, B.; et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics 2013, 14, 669. [Google Scholar] [CrossRef]
- Healy, B.; Cooney, S.; O’Brien, S.; et al. Cronobacter (Enterobacter sakazakii): An opportunistic foodborne pathogen. Foodborne Pathog Dis 2009, 7, 339–350. [Google Scholar] [CrossRef]
- López, M.; Blasco, L.; Gato, E.; et al. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the AdeABC efflux pump: virulence associated with quorum sensing. Front Cell Infect Microbiol 2017, 7, 143. [Google Scholar] [CrossRef] [PubMed]
- Hernández, S.B.; Cota, I.; Ducret, A.; Aussel, L.; Casadesús, J. Adaptation and preadaptation of Salmonella enterica to bile. PLoS Genet 2012, 8, e1002459. [Google Scholar] [CrossRef]
- Urdaneta, V.; Casadesús, J. Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts. Frontiers in Medicine 2017, 4, 163. [Google Scholar] [CrossRef] [PubMed]
- Belzer, C.; Kusters, J.G.; Kuipers, E.J.; van Vliet, A.H. Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 2006, 55, 1678–1679. [Google Scholar] [CrossRef]
- Jahani Sherafat, S.; Tajeddin, E.; Reza Seyyed Majidi, M.; et al. Lack of association between Helicobacter pylori infection and biliary tract diseases. Pol J Microbiol 2012, 61, 319–322. [Google Scholar] [CrossRef] [PubMed]
- Fatemi, S.M.; Doosti, A.; Shokri, D.; Ghorbani-Dalini, S.; et al. Is there a correlation between Helicobacter pylori and enterohepatic Helicobacter species and gallstone cholecystitis? Middle East J Dig Dis 2018, 10, 24–30. [Google Scholar] [CrossRef] [PubMed]
- Dar, M.Y.; Ali, S.; Raina, A.H.; et al. Association of Helicobacter pylori with hepatobiliary stone disease, a prospective case control study. Indian J Gastroenterol 2016, 35, 343–346. [Google Scholar] [CrossRef]
- Peng, Y.; Yang, Y.; Liu, Y.; et al. Cholesterol gallstones and bile host diverse bacterial communities with potential to promote the formation of gallstones. Microb Pathog 2015, 83–84, 57–63. [Google Scholar] [CrossRef] [PubMed]


| Patient number | Gender | Age (years) | AST (IU/L) | ALT (IU/L) | ALP (IU/L) | WBC (/μL) | BUN (mg/dL) | CRP (mg/dL) | Diseases | Culture and medical history | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aerobic culture | Anaerobic culture | Past medical history | ||||||||||
| 1 | Male | 31 | 25 | 30 | 400 | 7600 | 14 | 1 | CBD stone | Negative | Negative | Ischemic heart disease |
| 2 | Female | 57 | 294 | 560 | 1401 | 6700 | 22 | 0.8 | CBD stone | Negative | Negative | Diabetes mellitus |
| 3 | Female | 69 | 75 | 62 | 902 | 7600 | 32 | 2.4 | Jaundice | Pseudomonas | Negative | Not reported |
| 4 | Female | 55 | 17 | 15 | 757 | 7200 | 21 | 1.3 | CBD stone | Negative | Negative | Diabetes mellitus |
| 5 | Female | 72 | 12 | 40 | 150 | 5800 | 10 | 1 | CBD stone | Negative | Negative | Hypertension, diabetes mellitus |
| 6 | Female | 73 | 12 | 40 | 280 | 5200 | 25 | 0.9 | Epigastric pain | Negative | Negative | Pancreatic cancer |
| 7 | Male | 41 | 14 | 45 | 350 | 8600 | 23 | 0.9 | CBD stone | Pseudomonas | Negative | Cholecystectomy |
| 8 | Male | 37 | 16 | 46 | 450 | 7800 | 24 | 0.8 | CBD stone | Pseudomonas | Negative | Chronic kidney disease |
| 9 | Female | 42 | 13 | 42 | 340 | 5600 | 24 | 1 | Fever, hydatid cyst | Negative | Negative | Hypertension |
| 10 | Male | 45 | 182 | 147 | 808 | 8400 | 13 | 0.8 | Fever of unknown origin | E. coli | Negative | Previous sphincterotomy |
| 11 | Male | 38 | 50 | 18 | 357 | 41700 | 19 | 0.7 | Jaundice | E. coli | Negative | Not reported |
| 12 | Female | 15 | 45 | 58 | 2585 | 16700 | 14 | 0.9 | Epigastric pain | Negative | Negative | Pancreatic cancer |
| 13 | Female | 69 | 17 | 28 | 615 | 6300 | 11 | 0.7 | CBD stone | Negative | Negative | Hypertension |
| 14 | Female | 81 | 323 | 255 | 412 | 11500 | 17 | 0.8 | CBD stone | Pseudomonas | Negative | Cholecystectomy |
| 15 | Male | 62 | 22 | 16 | 768 | 25000 | 15 | 0.8 | CBD stone | Pseudomonas | Negative | Hypertension |
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | P11 | P12 | P13 | P14 | P15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WBC count | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | High | High | High | High | High |
| ALP | Moderate | Very high | High | High | Normal | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Drastically high | Moderate | Moderate | Moderate |
| CBD stone | CBD | CBD | No | CBD | CBD | No | CBD | CBD | No | No | No | No | CBD | CBD | CBD |
| Proteobacteria | 12498 | 25100 | 18181 | 3229 | 37149 | 13546 | 30128 | 10832 | 42912 | 47690 | 27902 | 31128 | 10198 | 33159 | 14657 |
| Firmicutes | 1023 | 11977 | 1505 | 16390 | 350 | 764 | 1 | 508 | 3803 | 255 | 6737 | 1481 | 3723 | 283 | 2616 |
| Bacteroidetes | 810 | 6 | 224 | 47 | 35 | 501 | 1 | 1781 | 0 | 2 | 1 | 12 | 669 | 18 | 410 |
| Cyanobacteria | 179 | 1 | 24 | 3 | 0 | 46 | 0 | 26 | 4 | 0 | 1 | 0 | 69 | 2 | 116 |
| Actinobacteria | 146 | 2 | 168 | 6 | 1 | 158 | 2 | 287 | 6 | 1 | 64 | 15 | 245 | 1 | 221 |
| Fusobacteria | 38 | 7586 | 3 | 2 | 0 | 9 | 0 | 77 | 1 | 0 | 1 | 0 | 579 | 1 | 154 |
| Acidobacteria | 20 | 0 | 0 | 2 | 0 | 4 | 1 | 104 | 0 | 0 | 0 | 0 | 0 | 2 | 59 |
| Deinococcus-Thermus | 12 | 0 | 0 | 2 | 0 | 0 | 0 | 68 | 0 | 0 | 0 | 0 | 7 | 0 | 0 |
| Candidatus Saccharibacteria | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Spirochaetes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 |
| Tenericutes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Spirochaetes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Relative abundance (%) | ||||
|---|---|---|---|---|
| CBD stone (mean ± SD) | Non-CBD stone (mean ± SD) | t test (p value) | t test (p value) | |
| Pseudomonadaceae_unclassified | 3.2 ± 4.2 | 8.2 ± 7.5 | NS | NS |
| Alphaproteobacteria_unclassified | 3.1 ± 4.9 | 0.2 ± 0.42 | 0.180 | <0.0001 |
| Enterobacteriaceae_unclassified | 8.8 ± 8 | 15.7 ± 10.9 | NS | NS |
| Gammaproteobacteria_unclassified | 2.6 ± 3.1 | 8 ± 7.6 | 0.080 | 0.026 |
| Helicobacter | 2.1 ± 3.6 | 0.8 ± 1.5 | NS | NS |
| Prevotella | 1.6 ± 2.5 | 0.5 ± 1.3 | NS | NS |
| Fusobacterium | 1.7 ± 1. 8 | 0.3 ± 0.5 | 0.083 | 0.013 |
| Aeromonas | 1.2 ± 1.8 | 0.3 ± 0.5 | 0.260 | 0.010 |
© GERMS 2023.
Share and Cite
Azimirad, M.; Sadeghi, A.; Hosseinkhan, N.; Mirbagheri, S.Z.; Alebouyeh, M. Microbiome Analysis of Bile Samples in Patients with Choledocholithiasis and Hepatobiliary Disorders. Germs 2023, 13, 238-253. https://doi.org/10.18683/germs.2023.1390
Azimirad M, Sadeghi A, Hosseinkhan N, Mirbagheri SZ, Alebouyeh M. Microbiome Analysis of Bile Samples in Patients with Choledocholithiasis and Hepatobiliary Disorders. Germs. 2023; 13(3):238-253. https://doi.org/10.18683/germs.2023.1390
Chicago/Turabian StyleAzimirad, Masoumeh, Amir Sadeghi, Nazanin Hosseinkhan, Seyedeh Zohre Mirbagheri, and Masoud Alebouyeh. 2023. "Microbiome Analysis of Bile Samples in Patients with Choledocholithiasis and Hepatobiliary Disorders" Germs 13, no. 3: 238-253. https://doi.org/10.18683/germs.2023.1390
APA StyleAzimirad, M., Sadeghi, A., Hosseinkhan, N., Mirbagheri, S. Z., & Alebouyeh, M. (2023). Microbiome Analysis of Bile Samples in Patients with Choledocholithiasis and Hepatobiliary Disorders. Germs, 13(3), 238-253. https://doi.org/10.18683/germs.2023.1390
